Data Provided by Refinitiv. Minimum 15 minutes delayed.

Data Provided by Refinitiv. Minimum 15 minutes delayed.


Press Releases
18-Mar-21

Innate Pharma reports Full Year 2020 financial results and business update

Marseille, March 18, 2021 (GLOBE NEWSWIRE) -- Lacutamab received PRIME designation from the European Medicines Agency in Sezary Syndrome; clinical development program advances in mycosis fungoides and peripheral T-cell lymphoma Company’s first NK cell engager selected by Sanofi as drug candidate

16-Mar-21

Innate Pharma announces conference call and webcast for Full Year 2020 financial results

Marseille, March 16, 2021 (GLOBE NEWSWIRE) -- Innate Pharma SA (Euronext Paris: IPH – ISIN: FR0010331421; Nasdaq: IPHA) (“ Innate ” or the “ Company ”), today announced that the Company will hold a conference call on Thursday, March 18, 2021 at 2 p.m. CET / 9 a.m.

24-Feb-21

Number of shares and voting rights of Innate Pharma as of February 1, 2021

Marseille, Feb. 24, 2021 (GLOBE NEWSWIRE) -- Pursuant to the article L. 233-8 II of the French “Code de Commerce” and the article 223-16 of the French stock-market authorities ( Autorité des Marchés Financiers , or “AMF”) General Regulation, Innate Pharma SA (the “Company” - Euronext Paris: